Cannara Biotech Inc. (TSXV:LOVE)
Canada
· Delayed Price · Currency is CAD 1.690
+0.020 (1.20%)
At close: Dec 5, 2025
Cannara Biotech Revenue
In the fiscal year ending August 31, 2025, Cannara Biotech had annual revenue of 107.20M CAD with 31.14% growth. Cannara Biotech had revenue of 28.52M in the quarter ending August 31, 2025, with 23.02% growth.
Revenue
107.20M
Revenue Growth
+31.14%
P/S Ratio
1.50
Revenue / Employee
237.17K
Employees
452
Market Cap
160.37M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Curaleaf Holdings | 1.78B |
| dentalcorp Holdings | 1.66B |
| Green Thumb Industries | 1.61B |
| Sienna Senior Living | 967.05M |
| Extendicare | 1.59B |
| Trulieve Cannabis | 1.66B |
| Cronos Group | 184.36M |
| WELL Health Technologies | 1.25B |